[Validity and limitations of the CEA test in the treatment of colorectal carcinoma].
CEA appears to be a good marker in the follow up of patients operated for colorectal cancer. The Authors analyse, on the base of literature data, the results of CEA test in their experience of colorectal cancers operated from 1978 to 1987. They confirm the importance of CEA as recurrence marker, however the test, by itself, is not sufficient to always identify a new onset of the disease.
Vuolo
G
G
De Stefano
A
A
Bovenga
S
S
Roviello
F
F
Piccolomini
A
A
Bruttini
S
S
Pinto
E
E
Lorenzoni
P
P
Ceccarini
C
C
D002272:Carcinoembryonic Antigen / Q000032:analysis*; D015179:Colorectal Neoplasms / Q000175:diagnosis* / Q000601:surgery; D005069:Evaluation Studies as Topic; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D009362:Neoplasm Metastasis; D013997:Time Factors
D002272:Carcinoembryonic Antigen
Validità e limiti del CEA test nel trattamento del carcinoma retto-colico.